It is a pleasure for KeMyth Biotech to introduce our products and platform technology as follows. Please join our booth for the details in Taiwan Healthcare+ Expo 2021.
(1) Rapid diagnostic kit: KeMyth product, Klebsiella pneumoniae serotype K1/K2 rapid testing cassette (Taiwan FDA License No.007019), has been used by medical centers in Taiwan, published in leading journals (2016, J Clin Microbiol, 54:3018-21; 2019, Gut Pathog, 11:11), and earned the 13th National Innovation Award in Taiwan.
(2) Platform technology: KeMyth product, antibiotic testing and screening system against superbugs, has been published in leading journals (2017, J Antimicrob Chemother, 72:3302-16; 2020, Int J Antimicrob Agents, 55:105918) and has been used by research institutes and pharmaceutical companies in Taiwan, USA, France, Japan etc. The U.S. patent number is US 10,760,110 B2.
(3) Drug development: a candidate drug to control type 2 diabetes, atherosclerosis, and body weight. The research results have been published in a leading journal (2020, Cells, 9(5):E1183) and the U.S. patent number is US 10,287,328 B2.
(4) Natural food: Exquisite Ginger Tea; Natural Capsules (Quintessential Ginger; Okra & Bitter Gourd Extract; Artichoke & Ginger Extract; Echinacea purpurea Extract & Vitamin C).
(5) Skin care: Purifying Hydration Mask.